Cigna Corporation (CI) Stock Price: $295.00+5.39 (+1.86%)
The total return cagr for Cigna Corporation (CI) stock is -3.20% over the past 12 months. The 3 year average growth rate is 5.51% and the 5 year cagr is 5.97%. Total return includes dividends reinvested.
The closing share price for Cigna Corporation (CI) stock was $295.00 for Tuesday, June 9, 2026, up +1.86% from the previous day.
CI Price Chart
CI Key Metrics
See All MetricsCI Earnings Preview
Next Earnings Date
Jul 30, 2026
51 days away
EPS Estimate
7.57
Revenue Est.
$70.10B
Last Quarter Results
EPS
$7.79
vs Estimate
$7.61
Revenue
$68.49B
vs Estimate
$66.29B
CI Analyst Ratings
Consensus Rating
Based on 24 analysts
Average Price Target
$340.92
+15.6% upside
Low
$290.00
Current
$295.00
High
$400.00
CI Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $8.30 | N/A | 5 |
| Q2 2027 | N/A | $8.19 | N/A | 5 |
| Q3 2027 | N/A | $8.49 | N/A | 5 |
| Q4 2027 | N/A | $8.44 | N/A | 5 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $33.43 | N/A | 14 |
| FY 2028 | N/A | $36.88 | N/A | 8 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $71.01B | N/A | 5 |
| Q2 2027 | N/A | $73.44B | N/A | 5 |
| Q3 2027 | N/A | $75.20B | N/A | 5 |
| Q4 2027 | N/A | $77.70B | N/A | 5 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $297.92B | N/A | 14 |
| FY 2028 | N/A | $313.51B | N/A | 8 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
CI Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1CI | $78.04B | $295.00 | +1.86% | -3.20% | +5.97% | +9.71% |
CI Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Cigna Corporation
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- David Michael Cordani